Andere Sprachen ResMed, Inc.

Aktien

895878

US7611521078

RMD

Medizinische Ausrüstung

Realtime-Estimate Cboe BZX Andere Börsenplätze 20:39:36 13.07.2026			% 5 Tage	Veränd. 1. Jan.
198,03 ^USD	-2,86 %		-9,52 %	-17,96 %

15:56	RESMED, INC. : Citigroup senkt seine Meinung und wechselt zu Neutral	ZM
09:01	RESMED INC. : Citigroup ist jetzt neutral	ZM

Andere Sprachen

09.07.	Resmed Insider Sold Shares Worth $1,090,771, According to a Recent SEC Filing
09.07.	ResMed's Sale of MatrixCare Shows Willingness to Recycle Capital From Rationalizing Underperforming Units, Jarden Says
09.07.	Morgan Stanley rates RMD as Equal-weight
08.07.	ResMed's $490 Million Sale of MatrixCare Not Material to Outlook, RBC Says
08.07.	Deals of the day-Mergers and acquisitions
08.07.	Australian Shares Fall; ResMed to Sell MatrixCare Business to Frazier Healthcare Partners for $490 Million
08.07.	ResMed to Sell MatrixCare Business to Frazier Healthcare Partners for $490 Million
08.07.	ResMed to sell software business MatrixCare for $490 million
07.07.	ResMed to Sell MatrixCare Business to Frazier Healthcare Partners
07.07.	Resmed Announces Agreement to Sell MatrixCare Business
07.07.	Frazier Management, L.L.C. agreed to acquire MatrixCare, Inc. from ResMed Inc. for $490 million.
30.06.	Resmed to Report Fourth Quarter Fiscal 2026 Earnings on August 6, 2026
29.06.	ResMed Inc.(NYSE:RMD) dropped from Russell Midcap Growth Benchmark
29.06.	ResMed Inc.(NYSE:RMD) dropped from Russell 3000E Growth Benchmark
29.06.	ResMed Inc.(NYSE:RMD) dropped from Russell 1000 Growth Benchmark
29.06.	ResMed Inc.(NYSE:RMD) dropped from Russell 1000 Growth-Defensive Index
29.06.	ResMed Inc.(NYSE:RMD) dropped from Russell 3000 Growth Benchmark
17.06.	ResMed Shares Fall After Morgan Stanley Downgrade
17.06.	Analyst recommendations: Block, Resmed, Applied Materials, Ge Vernova, Intel…
15.06.	Analyst recommendations: Accenture, Caesars Entertainment, Roku, Adobe, Salesforce…
12.06.	European Midday Briefing : Oil Falls After Trump Calls Off Iran Strikes
11.06.	Resmed at SLEEP 2026: Advancing Sleep Health Through Innovation in Screening, Diagnosis and Personalized Care
09.06.	Resmed Insider Sold Shares Worth $968,064, According to a Recent SEC Filing
04.06.	Australian shares fall as Mideast tensions deepen, miners and banks top losers
02.06.	ResMed Completes Acquisition of Noctrix Health